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The enzyme encoded by the ALOX15B gene has been linked
to the development of atherosclerotic plaques in humans and
in a mouse model of hypercholesterolemia. In vitro, these
enzymes, which share 78% sequence identity, generate distinct
products from their substrate arachidonic acid: the human
enzyme, a 15-S-hydroperoxy product; and the murine enzyme,
an 8-S-product. We probed the activities of these enzymes with
nanodiscs as membrane mimics to determine whether they can
access substrate esterified in a bilayer and characterized their
activities at the membrane interface. We observed that both
enzymes transform phospholipid-esterified arachidonic acid to
a 15-S-product. Moreover, when expressed in transfected HEK
cells, both enzymes result in significant increases in the amounts
of 15-hydroxyderivatives of eicosanoids detected. In addition,
we show that 15-LOX-2 is distributed at the plasma membrane
when the HEK293 cells are stimulated by the addition Ca2ⴙ
ionophore and that cellular localization is dependent upon the
presence of a putative membrane insertion loop. We also report
that sequence differences between the human and mouse
enzymes in this loop appear to confer distinct mechanisms of
enzyme-membrane interaction for the homologues.

A macrophage 15-lipoxygenase (15-LOX)2 activity has been
linked to elevated levels of oxidized lipids through several
experimental approaches that include the heterologous expression of human 15-LOX in a mouse model of hyperlipidemia (1)
and pharmacological inhibition of 15-LOX activity (2, 3). These
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lipid oxidation products can enter the extracellular pool of cholesterol esters transported by LDL (4) and promote the pathological consequences of elevated LDL cholesterol levels (5).
Macrophages that take up LDL laden with oxidized lipids are
transformed to foam cells, an event that leads to further inflammation and apoptosis and results in the formation of atherosclerotic plaques. Recently, Magnusson et al. (6) demonstrated
that silencing production of 15-LOX-2 (the product of the
ALOX15B gene) in human macrophages decreased cellular
lipid accumulation, the precipitating factor in foam cell formation. These results suggest that inhibition of 15-LOX-2 is a
strategy for mitigating the development of cardiovascular
disease.
Lipoxygenases oxygenate arachidonic acid (AA) to form a
stereo- and regiospecific isomer of hydroperoxyeicosatetraenoic acid (HpETE), and isoforms are named according to
which carbon atom is oxygenated (for review see Refs. 7 and 8).
In general, within a species, lipoxygenases that differ in regiospecificity share ⬃40% sequence identity. In contrast, betweenspecies LOX homologues are expected to share ⬃75% or better
sequence identity and generate the same HpETE isomer. The
mouse homologue of human 15-LOX-2, however, is an 8-LOX
(m8S-LOX) with free AA as the substrate, and this altered
regiospecificity appears to be unique to the mouse enzyme (9).
We asked whether at the membrane and in a cellular context
the mouse enzyme might also generate a 15-HpETE product.
This information might provide insight into interpreting
atherosclerosis studies that employ a murine model of hypercholesterolemia.
We recently reported the crystal structure of 15-LOX-2 and
described a possible membrane insertion loop and open active
site on one face of the elongated protein that would appear to
make it feasible for the enzyme to access AA esterified in a
membrane phospholipid (PL) (10). We show that in vitro both
m8S-LOX and 15-LOX-2 generate the 15-isomer of the product with PL-esterified substrate in a nanodisc membrane
bilayer mimic. However, we observed that the homologues differ in their ability to fully process the discreet pools of substrate
in separate nanodiscs. In addition, we report that HEK293 cells
transfected to express the mouse-8-S enzyme show elevated
levels of 15-peroxidation products of polyunsaturated fatty
acids (PUFA), whereas these products are not observed with
enzymes incubated with free PUFA in vitro. Moreover, we demonstrate with immunofluorescence data that 15-LOX-2 localizes to the plasma membrane upon Ca2⫹ stimulation.
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 1. Enzyme activity in a nanodisc assay. A, electrospray ionization MS analysis of the 15-LOX-2 and m8S-LOX reactions with nanodiscs. Nanodiscs (25%
SAPC, 75% POPC, 5 M in 50 mM potassium phosphate (pH 7.4), 0.1 mM EDTA, 100 mM NaCl, and 2 mM CaCl2) were incubated with 2.2 M 15-LOX-2 or 6 M
m8S-LOX for 5 h at room temperature, after which the PL fraction was extracted with the Bligh-Dyer method. Mass spectrometry analysis was performed in
positive ion mode. Products with molecular weights of m/z 826.6 and 842.6 are consistent with oxygenation of SAPC. These peaks were not observed in the
absence of enzyme, only the peak corresponding to unmodified SAPC (m/z 810.6). In the absence of Ca2⫹, oxygenated SAPC was observed to a lesser extent
for 15-LOX-2. B, HPLC-based assay to determine the regiospecificity of 15-LOX-2 (top panel) and m8S-LOX (bottom panel) with nanodiscs. 15-LOX-2 (2 M) or
m8S-LOX (6 M) was incubated with 5 M of nanodiscs (25% SAPC, 75% POPC) for 5 h at room temperature in a 400-l reaction volume. Subsequently, the
sample was incubated at 85 °C to inactivate the LOX and then incubated with 1 mg/ml PLA2 (37 °C, 2.5 h) to cleave the PL. Free fatty acids for HPLC analysis were
isolated by solid phase extraction with C18 columns, and the peroxides were reduced to the corresponding alcohols with the addition of TPP. Only the 15-HETE
isomer (solid line) is detected. The dashed lines provide the elution times for HETE standards.

Results
Enzyme Activity with a Bilayer Mimic—Binding of 15-LOX-2
to nanodiscs was previously demonstrated by analytical size
exclusion chromatography (10), and these results established
the conditions to investigate membrane-associated enzyme
activity with nanodiscs as substrates. The activities of 15LOX-2, m8S-LOX, and their loop mutants were monitored
with AA covalently attached to phospholipids in nanodiscs
containing 25% 1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine (SAPC) as substrate. The product HpETE (or the
corresponding alcohol generated by its non-enzymatic reduction, a hydroxyeicosatetraenoic acid (HETE)) covalently bound
to the PL was first detected by electrospray ionization TOF MS.
As shown in Fig. 1A, products with molecular weights of m/z
826.6 and 842.6, consistent with the addition of -OH and
-OOH, respectively, to SAPC were detected when 15-LOX-2 or
m8S-LOX were present in the reaction mixture. The hydroperoxy products are often rapidly reduced to their corresponding
alcohols with the extraction procedure employed. Only the
peak corresponding to unmodified SAPC (m/z 810.6) was
observed in the negative control reactions without 15-LOX-2
or m8S-LOX. In the absence of Ca2⫹, less product was detected
for 15-LOX-2.
The regiospecificity of the reaction was established by
reverse phase HPLC of the phospholipase A2-cleaved products
(Fig. 1B). (Prior to HPLC analysis oxygenated fatty acids are
reduced; thus detected products are HETEs rather than
HpETES.) When either 15-LOX-2 or m8S-LOX were incubated with PL-esterified-AA containing nanodiscs, only
15-HETE was formed as product, as opposed to 8-HETE or a
di-HETE, the products observed with m8S-LOX and free AA
(9, 11).
Fatty Acid and Head Group Preferences—Inositol-PL are
enriched with esterified PUFAs in cells; thus nanodiscs containing
PL-esterified polyunsaturated fatty acids carrying an inositol head
group were used to generate time course data and measure rate
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constants for the reaction. HPLC-based time course assays were
performed with 15-LOX-2 and m8S-LOX on nanodiscs composed of 40% 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC), 25% 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine
(POPS), and 35% L-␣-phosphatidylinositol (Avanti Polar Lipids).
This commercial phosphatidylinositol contains 17% AA and 13%
dihomo-␥-linolenic acid (DGLA) according to the fatty acid distribution data from Avanti Polar Lipids, Inc. Thus both AA (20:4)
and DGLA (20:3) substrates were available in these nanodiscs, creating an opportunity to compare enzyme activities with two substrates. The time course of product formation (both 15-HETE
from AA and 15-hydroxyeicosatrienoic acid (15-HETrE) from
DGLA) by m8S-LOX and 15-LOX-2 with these “mixed PI” containing nanodiscs is shown in Fig. 2A. The data were fit to a onephase association equation using GraphPad Prism. The amount of
product formed by 15-LOX-2 was 6 –10 times higher than by
m8S-LOX, and m8S-LOX generated more product from DGLA
even though there was less of this substrate in the nanodiscs. The
observed rates of the reactions were 0.0263 ⫾ 0.0017 min⫺1 for
m8S-LOX/15-HETE, 0.0373 ⫾ 0.0035 min⫺1 for m8S-LOX/15HETrE, 0.0573 ⫾ 0.0122 min⫺1 for 15-LOX-2/15-HETE, and
0.0582 ⫾ 0.0107 min⫺1 for 15-LOX-2/15-HETrE.
The L-␣-phosphatidylinositol containing nanodiscs were
also utilized to compare the wild-type activities of the homologues with those of their loopless counterparts (⌬73–79:15LOX-2 and ⌬74 – 81:m8S-LOX). In these experiments, the
reactions were stopped at 40 min for analysis (Fig. 2B). Consistent with the time course data in Fig. 2A, 15-LOX-2 generated
more product (⬎15-fold) than m8S-LOX for the same amount
of substrate in nanodiscs. A possible mechanistic reason for this
substantial difference in product formation is discussed below.
These data suggest a preference for reaction with PL-DGLA
over PL-AA for the mouse enzyme, whereas the activity at the
membrane of the human enzyme was highly dependent on the
presence of the putative membrane insertion loop. The absence
of the putative membrane insertion loop in the human enzyme
VOLUME 291 • NUMBER 37 • SEPTEMBER 9, 2016
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FIGURE 2. 15-LOX-2 and 8-LOX activities with inositol phospholipids. A, HPLC-based time course assay with nanodiscs composed of 40% POPC, 25% POPS,
and 35% L-␣-phosphatidylinositol. The enzyme concentration was 3 M in both sets of reactions; nanodisc concentrations were 10 and 15 M for m8S-LOX and
15-LOX-2 reactions, respectively. Aliquots taken at the different time points were incubated at 85 °C to inactivate the LOX and subsequently cleaved with PLA2
(37 °C, 2.5 h) to liberate free fatty acids. After solid phase extraction and the addition of TPP, oxidized fatty acids were quantitated by HPLC. The data were fit to
a one-phase association equation with GraphPad Prism. The amount of product formed by 15-LOX-2 is 6 –10 times higher than m8S-LOX. B, comparison of
15-LOX-2 and m8S activities and their loopless variants (LM). Reactions (2 mM Ca2⫹, 3 M enzyme, and 15 M nanodiscs) were performed in 40 l. Nanodiscs
contained 40% POPC, 25% POPS, and 35% L-␣-phosphatidylinositol from bovine liver. The L-␣-phosphatidylinositol is composed of 17% AA and 14% DGLA,
which give 15-HETE (dark gray bars) and 15-HETrE (light gray bars) as products, respectively. Incubations were performed at 37 °C for 40 min and enzymes
inactivated at 82.5 °C for 50 min before treatment with PLA2 to liberate the oxidized fatty acids for HPLC analysis.

resulted in a ⬃50% decrease in product. As much of a dramatic
decrease in product generated by the mouse counterpart was
not observed.
As a means to probe a head group preference for 15-LOX-2,
the amount of product formed from AA-esterified nanodiscs
of various head group compositions was evaluated. The
15-LOX-2 products of choline, ethanolamine, and inositol PL
that carry stearate and arachidonate acyl groups (SAPC, SAPE,
and SAPI, respectively) were measured at two time points of 15
min (Fig. 3A) and 90 min (Fig. 3B). All of the reactions were
conducted in the presence and absence of Ca2⫹. At 15 min,
there was a significantly higher amount of product from SAPC.
At the later time point, the product from SAPI achieved a very
similar level to that from SAPC; however the product from
SAPE was still significantly lower. For all head groups, the presence of Ca2⫹ increased product yields significantly. These
results suggested a selectivity, rather than specificity, for head
group, which might be explained by enzyme-head group
interactions.
Access to Membrane-embedded Substrates—Enzymes that
must access substrate in the bilayer may do so in a processive
manner where they are able to move along the membrane to
process multiple substrate molecules with a single binding
event (scooting mode) or in single turnover mode (hopping
mode), in which an enzyme membrane collision is required for
each turnover (12, 13). These modes are readily distinguished in
a nanodisc assay by the addition of fresh enzyme or substrate to
reactions that have been allowed to go to completion. The addition of enzyme to a completed reaction should result in an
increase in product only if enzyme functions in scooting mode
and is not able to “hop” between nanodiscs to consume all substrate molecules. In contrast, increased product yields because
of nanodisc addition is an indication that the enzyme functions
in hopping mode because it can readily translocate to the new
nanodiscs provided, and the reaction has gone to completion
simply because all substrate has been consumed. Fig. 4 shows
the results of such experiments for m8S-LOX and 15-LOX-2.
The reactions in the top panel were performed with 3 M m8SLOX and 10 M nanodiscs containing 40% POPC, 25% POPS,
SEPTEMBER 9, 2016 • VOLUME 291 • NUMBER 37

FIGURE 3. Head group preference and nanodisc composition for
15-LOX-2. Reaction of 15-LOX-2 with nanodiscs composed of AA-bearing
PL of distinct head groups, with and without 2 mM Ca2⫹. Reaction volumes
were 40 l. Enzyme and nanodisc concentrations were 3 and 15 M,
respectively. For each experiment, the substrate PL made up 30% of the
bilayer lipids, enough to generate 9.2 g of product. SAPE and SAPC were
also evaluated in nanodiscs, which contained 30% PS:40%PC in the nonsubstrate PL to minimize any impact of a high concentration of positively
charged head groups at the bilayer. With shorter incubation times, SAPC
product yields were by far the best, and they were achieved in the presence of PS. However, note that PS has little effect on the activity measured
with SAPE as the substrate. However, upon extended incubation, product
yields from SAPI and SAPC are comparable. Reactions were performed at
37 °C for 15 min (A) or 90 min (B), after which the enzyme was heat-inactivated, and PL was cleaved with PLA2.
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FIGURE 4. Do m8S-LOX or 15-LOX-2 hop between nanodiscs? Top panel,
reactions mixtures of 3 M m8S-LOX and 10 M nanodiscs containing 40%
POPC, 25% POPS, and 35% L-␣-phosphatidylinositol from bovine liver. After
80 min, when the reaction almost reached completion, either fresh m8S-LOX
(⫹E) or nanodiscs (⫹ND) were added for an additional 80 min. In another set
of reactions, EDTA and free linoleic acid were added to verify the enzyme is
active, and a HODE product was confirmed (the inset is an HPLC trace). Bottom
panel, reactions of 3 M 15-LOX-2 with 15 M nanodiscs were incubated for 45
min to reach completion, and either fresh 15-LOX-2 (⫹E) or nanodiscs (⫹ND)
were added to the samples for a second 45-min incubation. Both 15-HETE
(dark gray bars bars) and 15-HETrE (light gray bars) were quantitated.

and 35% L-␣-phosphatidylinositol from bovine liver. After 80
min, when the reaction was almost complete, either more m8SLOX or nanodiscs were added to the reaction for an additional
80 min. There was more product formed only after addition of
more enzyme, which suggested the m8S-LOX remains “stuck”
on the nanodisc after substrate was consumed. As a control,
EDTA (to promote enzyme release from the bilayer) and free
linoleic acid (LA) were added at the end of 80 min to establish
that the enzyme was still active, and the corresponding reduced
hydroxyl product was observed (Fig. 4, top panel, inset). In comparable reactions with 15-LOX-2 (Fig. 4, bottom panel), only
the addition of fresh nanodiscs resulted in further product generated, an indication that the entire available substrate pool had
been consumed by 15-LOX-2. Thus 15-LOX-2, even in the
presence of Ca2⫹ to promote membrane binding, was able to
hop among nanodiscs. This observation is consistent with the
fact that 15-LOX-2 generates more product than 8-S-LOX in
assay conditions that require access to discrete pools of substrate (Fig. 2).
Activity with Esterified versus Free Substrates—Because the
nanodisc assays indicated that the mouse enzyme transforms
PL-esterified DGLA more readily than the AA counterpart, we
asked whether free DGLA or its ethyl ester derivative were sub-
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strates (Fig. 5 and Table 1). 15-LOX-2 with AA displayed substrate inhibition, whereas no substrate inhibition was observed
with DGLA (Fig. 5A); m8S-LOX showed substrate inhibition
with both AA and DGLA, and DGLA was a poorer substrate
than AA as the free fatty acid. The kcat/Km values for the two
substrates for 15-LOX-2 are 0.264 ⫾ 0.121 and 0.0895 ⫾ 0.0075
s⫺1 M⫺1 for AA and DGLA, respectively, which suggested a
slight preference for AA (Table 1). A preference was not
observed for the ethyl esters of the substrates because the
kcat/Km values were 0.0464 ⫾ 0.0084 s⫺1 M⫺1 versus 0.0335 ⫾
0.0056 s⫺1 M⫺1. The free substrates with m8S-LOX displayed
considerable substrate inhibition, and enzymatic parameters
suggested that both kcat and catalytic efficiency were less for
DGLA than for AA, which was the opposite of that observed
with nanodisc products for m8S-LOX. The ethyl ester substrates with m8S-LOX did not yield enough activity to be
analyzed.
Products Observed in Transfected HEK293 Cells—Supplementation conditions to enhance the PUFA content of the
HEK cell membranes were established (Fig. 6A). Exogenous
15-LOX-2 was added to crude cell lysates to transform AA and
LA to the corresponding hydroperoxides. The products that
were PL-esterified were liberated by the addition of PLA2. Note
that lysates from cell cultures grown without supplementation
had minor amounts of product in the free fatty acid pool, and
this amount was increased when PLA2 was added to release
additional free fatty acids. Lysates from cells cultured in supplemented media yielded at least 5-fold more free and PLA2-released 15-HETE. Moreover, most of the 15-HETE was only
detected after treatment with PLA2, likely an indication that
product was generated as the esterified substrate.
The results of MS lipidomics analyses of the oxidized fatty
acids found in HEK293 cells transfected with pCDNA3.1(⫹)
encoding either the 15-LOX-2 or m8S-LOX are shown in Fig.
6B. We asked whether unesterified LOX products indicative of
activity at the bilayer might be identified in the cellular pools of
free fatty acids. Because the mouse enzyme only generates
15-HETE from AA as the PL-ester, the presence of 15-HETE in
cell lysates of cells expressing m8S-LOX likely reflects enzyme
activity at the membrane. The presence of 15-HETrE in cell
lysates is also consistent with m8S-LOX activity at the membrane, given the fact that the free DGLA is a poor substrate.
For analysis, cells were first washed to remove extracellular
free fatty acids and then stimulated with Ca2⫹ ionophore to
induce membrane binding of the LOX. Application of ionophore was also expected to activate PLA2. For cell expressing
15-LOX-2, we could not differentiate between products generated as phospholipid esters or free fatty acids, but these
cells clearly yielded elevated levels of 15-HETE and 15-HETrE. For the m8S-LOX-expressing cells, both products were
detected at levels comparable with those observed in the
15-LOX-2 transfected cells. The high levels of 8-HETE and
9-HODE in these same extracts reflected activity with free
AA and LA, respectively.
However, for HEK cells expressing m8S-LOX, additional
products to those predicted from the in vitro nanodisc and
free AA data are observed. An apparent loss of specificity has
been reported for lipoxygenases when the reaction is slow
VOLUME 291 • NUMBER 37 • SEPTEMBER 9, 2016
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FIGURE 5. Reactions of 15-LOX-2 (A) and m8S-LOX (B) with free fatty acids: AA and DGLA. Reactions (in 50 mM Tris, pH 7.5, 150 mM NaCl, 0.5 mM EDTA, with
the addition of 5% glycerol for m8S-LOX) were monitored in UV spectrophotometer (237 nm). The enzyme concentration was 0.2 M, and substrate varied from
1 to 40 M. For assays with ethyl-esters, 20 mM cholate was included. The Michaelis-Menten equation with substrate inhibition was fitted to the curves using
least squares fitting in GraphPad Prism. Substrate inhibition is more pronounced for m8S-LOX, and there is no substrate inhibition for 15-LOX-2 with DGLA as
substrate. For m8S-LOX, free DGLA is a poorer substrate than AA. The kinetic parameters of the two substrates with 15-LOX-2 are similar. Kinetic parameters are
summarized in Table 1.

TABLE 1
Kinetic parameter

AA15-LOX-2
DGLA15-LOX-2
AAm8S-LOX
DGLAm8S-LOX
AA-EE15-LOX-2
DGLA-EE15-LOX-2

kcat

Km

kcat/Km

Ki

s⫺1

M

s⫺1 M⫺1

M

0.46 ⫾ 0.09
0.31 ⫾ 0.01
0.22 ⫾ 0.07
0.045 ⫾ 0.004
0.13 ⫾ 0.01
0.211 ⫾ 0.014

1.74 ⫾ 0.72
3.46 ⫾ 0.27
2.86 ⫾ 1.51
0.964 ⫾ 0.186
2.80 ⫾ 0.46
6.30 ⫾ 0.97

0.264 ⫾ 0.121
0.0895 ⫾ 0.0075
0.0758 ⫾ 0.0467
0.0467 ⫾ 0.0099
0.0464 ⫾ 0.0084
0.0335 ⫾ 0.0056

32.6 ⫾ 9.6
N/A
9.77 ⫾ 2.20
6.28 ⫾ 0.49
N/A
N/A

FIGURE 6. Oxidized fatty acids in HEK cells supplemented with AA and LA. A, non-transfected HEK cells supplemented with LA and AA provide substrates
for exogenous 15-LOX-2. Treatment of the 15-LOX-2/lysate incubations with PLA2 releases additional 15-HETE and 13-HODE. B, oxidized free fatty acids in
HEK293 cells transfected to express 15-LOX-2 (black) or m8S-LOX (striped) are increased over levels observed in non-transfected cells (stippled) similarly
enriched with LA and AA. The free fatty acid pool in 15-LOX-2 cells is enriched in 15-HETE and 13-HODE, those products observed in vitro with unesterified
substrates. In contrast, elevated levels of various HETEs are observed in those cells transfected with the m8S-LOX, whereas only the 8-HETE product is observed
with the unesterified substrate in vitro. The 9-HODE is the product of the reaction with free LA, and 13-HODE is generated from PL-esterified LA.

because the enzyme must work on a membrane embedded
PL (14) or at low O2 concentrations (15) (see below). These
same off target products have been detected in mouse lipidomics studies and are observed in 5-LOX and 12/15-LOX
knock-out mice (16).
Cellular Localization of 15-LOX-2—Earlier experiments with
15-LOX-2 have demonstrated a Ca2⫹-dependent association
with the membrane fraction in cell lysates (17). In addition,
15-LOX-1 is found in both cytosolic and membrane fractions
upon Ca2⫹ stimulation (18). 5-LOX has been shown to localize
to the nuclear membrane where the helper protein 5-lipoxygenase-activating protein is located (19), although nuclear membrane localization does not require the presence of the its transSEPTEMBER 9, 2016 • VOLUME 291 • NUMBER 37

membrane partner (20). Immunofluorescence detection of
15-LOX-2 expressed in transfected HEK293 cells was performed to reveal the cellular location of 15-LOX-2 upon stimulation with the Ca2⫹ ionophore. Under these conditions, wildtype 15-LOX-2 was detected with a distribution similar to that
of a pan-cadherin antibody, a marker for the plasma membrane.
In addition, neither the loopless 15-LOX-2 or 15-LOX-2 in
which the Ca2⫹ binding amino acids had been mutated to Ala
revealed this same pattern of distribution upon stimulation
(Fig. 7); both variants have wild-type enzymatic properties with
free AA as the substrate (10). Only the wild-type enzyme displays an antibody distribution pattern consistent with that of
the plasma membrane marker.
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 7. Cellular localization of 15-LOX-2 expressed in HEK293 cells.
Upon stimulation by addition of Ca2⫹ ionophore A23187, only the distribution of wild-type 15-LOX-2 conforms to that of the plasma membrane marker
Cadherin. Green, cadherin; red, 15-LOX-2. A, HEK cells expressing wild-type
15-LOX-2, without Ca2⫹ stimulation. B–D, in the box, wild type (B), ⌬73–79:15LOX-2 (LM) (C), and D39A:E44A:D85A:15-LOX-2 (D), all after Ca2⫹ simulation.

Discussion
The crystal structure of human 15-LOX-2 revealed an open
active site and a Ca2⫹-stabilized putative membrane insertion
loop along one face of the enzyme, raising the possibility that
the enzyme can access the PL-esterified AA groups of membrane phospholipids and thus not be dependent on a phospholipase activity to liberate its fatty acid substrates (Fig. 8). A distinct mechanism for substrate acquisition by 15-LOX-2 could
provide a context for development of isozyme-specific inhibitors in this enzyme family and circumvent the fact that the core
active site and catalytic machinery are so highly conserved
among the various lipoxygenases (10, 21–24). 15-LOX-2 activity with solubilized phospholipids was previously reported (25).
In this work, we asked whether 15-LOX-2 might process esterified AA in bilayer phospholipids encompassed in nanodiscs. In
addition, we looked at the same reaction with the mouse homologue of 15-LOX-2, which generates exclusively the 8-S-isomer
of the hydroperoxy product from free AA, rather than the 15-S,
and eventually a di-HETE product. Although the activity of the
mouse enzyme at the bilayer was reduced relative to that of the
human enzyme, the enzyme was able to process the membraneembedded substrate and yield only the 15-S-isomer of HETE;
the 8-S-isomer was not detected. In addition, immunofluorescence studies indicated that 15-LOX-2 translocated to the
plasma membrane upon Ca2⫹ stimulation, and this translocation required the putative membrane insertion loop that projected from the amino-terminal ␤-barrel domain. In contrast,
the same ␤-barrel domain in 5-LOX targets it to the nuclear
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membrane (26 –28). Finally, HEK293 cells transformed to
express the 15-LOX-2 and m8S-LOX enzymes yielded
increased pools of both 15-HETE and 15-HETrE (as well as
8-HETE for the 8-enzyme). In vitro, only the action of the
mouse enzyme on PL-esterified AA or DGLA (the precursor to
HETrEs) generates 15-HETE or 15-HETrE, respectively. Neither free DGLA nor its ethyl ester were transformed to the
HETrEs by the 8S-enzyme at an appreciable rate. We might
infer from these results that in a cellular context the m8S-enzyme can process PL-esterified PUFAs and lead to the production of 15-HETrEs and 15-HETEs. From the experiments with
15-LOX-2-expressing HEK293 cells, we were unable to conclude that the enzyme generated 15-HETE as the PL-ester in a
cellular context. However, our data from incubations of exogenous 15-LOX-2 incubated with lysates of PUFA-enriched
untransfected HEK293 cells strongly hinted at a significant
membrane-bound activity for this enzyme as well (Fig. 6A).
Exogenous PLA2 was added after heat inactivation of
15-LOX-2, and the free 15-HETE levels increased over 5-fold
once the incubations were treated with the phospholipase.
The mouse and human enzymes encoded by the ALOX15B
genes share 78% sequence identity at the amino acid level, yet
the products of these enzymes differ with respect to regiospecificity with AA as the common substrate. This difference in positional specificity is conferred by the substitution of Asp-602
and Val-603 deep in the 15-LOX-2 binding pocket with Tyr-His
in the mouse enzyme. Site-directed mutagenesis of these two
amino acids to their 15-LOX-2 counterparts converts the 8-S
enzyme to a 15-S enzyme (29). As one can see from Fig. 8 (A–C),
Val-603 sits at the deepest part of the AA binding site, positioned to define the depth of the binding pocket and abut C20 of
the substrate so that C15 can be positioned for oxygenation.
The altered specificity of the mouse 8-S-enzyme is explained
by the fact that a His at this position could favor the reverse
orientation of substrate: the carboxyl end entering deepest to
interact with the His. This inverse entry model is consistent
with the stereochemistry of the product as well, because it can
position C8 of the substrate for oxygenation to a product with
S-stereochemistry (Fig. 8D).
A sequence database search for m8S-LOX homologues
retrieved 80 unique sequences with as little as 72% overall
sequence identity to the mouse enzyme. Although all but one of
these sequences maintain the insertion in the amino-terminal
␤-barrel domain that appears to serve as a membrane binding
loop, only the mouse enzyme has a His rather than a Val, Ile, or
Met at the position corresponding to Val-603 in 15-LOX-2 (Fig.
9). This suggests that only the mouse ALOX15B enzyme directs
carboxyl-first binding of free AA into the active site pocket.
However, if the cellular substrate is the PL-esterified PUFA, the
bulky PL head group cannot be accommodated innermost in
the cavity, and the PUFA must enter methyl end first, making
the mouse enzyme a de facto 15-S-LOX. This possible in vivo
15-activity rather than 8-activity has important implications for
the use of mouse model systems (ApoE⫺/⫺ or LDLR⫺/⫺) to
study atherosclerosis (30).
Rao and co-workers (31) have observed that 15-HETE (generated by the non-enzymatic reduction of the product of a
15-LOX to the corresponding alcohol) contributes to atheroVOLUME 291 • NUMBER 37 • SEPTEMBER 9, 2016
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FIGURE 8. Human 15-LOX-2. A, cartoon rendering of the 15-LOX-2 structure. The putative membrane insertion loop (residues 70 – 85) is colored in black. Fe2⫹
and Ca2⫹ are represented by rust and purple spheres, respectively. A competitive inhibitor, the detergent C8E4, is shown in red. Amino acids Asp-85 (Ca2⫹
ligand) and Val-603 are shown in stick rendering. B, schematic showing how direction of substrate entry determines product stereochemistry. The LOX reaction
involves the abstraction of a hydrogen from the central carbon of a pentadiene followed by the oxygenation of the incipient free radical on the opposite side
of the substrate. In this drawing, the iron (red sphere) sits below the plane of the figure and the O2 (blue spheres) accesses the free radical from above. In the top
panel, (for 15-S product), the tail slides in to position C13 for attack, whereas in the bottom panel (for 8-S product), the AA slides in carboxyl first, presumably into
a slightly deeper cavity, such that C10 is positioned for attack. C, a slab of the corresponding surface rendering is shown such that the contours of the fatty acids
binding site are apparent. D, a close-up of the binding cavity. Superimposed on the 15-LOX-2 plus inhibitor structure is a phospholipid as observed in the LOX
from Pseudomonas aeruginosa (4G32 and 4G33 (49)). Note that the funnel-shaped cavity of 15-LOX is of sufficient size to accommodate a PL head group.

FIGURE 9. Sequence conservation in the membrane insertion loop and
cavity regions. A, the hydrophobicity and rigidity of the membrane insertion
loop of 15-LOX-2 is well conserved in 15-LOX-2 homologues. The sequence of
this region in the m8S-LOX deviates from this rule. B, 15-LOX-2 homologues
have a hydrophobic amino acid at the deepest part of the binding cavity. The
mouse sequence is an outlier in this region with a His at the corresponding
position. This figure was generated with WebLogo (50, 51) from a ClustalW
(52, 53) multisequence lineup of 80 homologous retrieved with the mouse
8-S-LOX sequence.

sclerosis in the ApoE⫺/⫺ murine model. Mice express a 12/15lipoxygenase as well as the 8S-enzyme, and it has been linked to
the production of 15-HETE (32). However, in a lipidomics
study Demetz et al. (16) performed with ALOX12/15-LOX⫺/⫺
SEPTEMBER 9, 2016 • VOLUME 291 • NUMBER 37

(the 15-LOX-1 or ALOX15A, homologue) knock-out mice, the
level of 12-HETEs detected fell to less than 50% of that of the
wild-type mouse, whereas a comparable, or significant, drop in
15-HETE levels was not detected. These data support our suggestion that m8S-LOX may generate 15-HETE in a cellular context, because these knock-out mice generate 15-HETE in the
absence of the 15-LOX-1 counterpart (⬃40% sequence identity
with 15-LOX-2). Moreover, Magnusson et al. (6) have demonstrated that ALOX15B gene-silencing experiments in human
primary macrophages decrease cellular lipid accumulation and
that the equivalent knockdown in a murine model (LDLR⫺/⫺)
leads to a reduction in markers of atherosclerosis.
The Role of the Membrane Insertion Loop—The crystal structure of 15-LOX-2 revealed two Ca2⫹ binding sites at the base of
a hairpin-like loop that emanates from the membrane binding
amino-terminal domain. Phospholipase A2, which hydrolyzes
esterified AA from the phospholipid bilayer upon Ca2⫹-stimulated membrane binding, also harbors a separate Ca2⫹-dependent membrane-binding domain (33). Kinetic studies with
PLA2 indicate that it can process multiple substrates before
falling off the membrane and reassociating for further action,
i.e. it scoots along the membrane to acquire more substrate as
the off rate for membrane binding is slow (34, 35). An alternative mechanism for interfacial enzymes that function at the
bilayer where off-rates for binding are fast relative to the catalytic turnover is referred to as a hopping mode. In this mode of
action, the enzyme hops from one contact point to the next.
The use of nanodisc assays allows one to readily distinguish
JOURNAL OF BIOLOGICAL CHEMISTRY
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between these modes of action, because an enzyme that is free
to hop among the nanodiscs can reach all available substrate. In
a cellular context, a hopping enzyme might be able to more
easily access distinct pools of substrate. On the other hand, a
scooting enzyme may have prolonged access to membrane-embedded substrate.
We found that the membrane insertion loop of 15-LOX-2
was required for full enzyme activity at the membrane, because
deletion of the loop lowers both the rate and amount of product
detected. In contrast, with its putative membrane insertion
loop, m8S-LOX cannot hop between nanodiscs, and deletion of
the loop has little impact on the amount of product formed.
Note that the loop is a second region of sequence divergence
between the mouse and human enzyme where the mouse
sequence is an outlier in a line-up (Fig. 9).
Influence of the Phospholipid Head Group—Comparison of
15-LOX-2 activity with PL bearing different head groups
reveals that it may discriminate among the phospholipids. Choline appears to be the preferred head group, over ethanolamine
or inositol, because more product is accumulated at the earlier
time point (15 min) with PC. Plasma membranes are generally
composed of 39% PC, 23% PE, 9% PS, and 8% PI (36). Although
zwitterionic PC and PE are abundant in biological membranes,
PI phospholipids carry 20 times more AA than PS-containing
PL in lipidomic analysis of the human plasma (37). Thus it was
important to evaluate the effect of the PI head group as well. A
more thorough investigation of head group preference with a
facile continuous assay suited to high throughput format is warranted, but at this point we can conclude that PC-, PI-, and
PE-bearing PL are all substrates for 15-LOX-2. There is, however, a preference for PC and PI, which, interestingly, are both
bulkier than PE. As one can see in Fig. 8, there is sufficient room
in the large crevice that narrows like a funnel to the substrate
binding site to accommodate a PL head group and confers some
sort of selection mechanism. It is possible that the less bulky PE
head group permits the fatty acid to enter further into the substrate tunnel and adopt a non-productive conformation.
PUFA Preference Is Context-dependent—Using the nanodisc
assay, we were able to directly observe a substrate preference
among esterified PUFA not observed for the free fatty acid substrates. Moreover, analysis of the cell extracts indicated that
this preference may reflect an activity in a cellular context. The
mouse enzyme preferentially processes PI-esterified DGLA
over its AA counterpart in the nanodisc assays. Cell extracts
from HEK cells that have been transfected to express the 8S-enzyme show increases in 15-HETrE over non-transfected cells.
Free DGLA or its ethyl ester are poor substrates for the mouse
enzyme; the enzyme is ⬃5-fold more active with free AA than
free DGLA, and free DGLA displays potent substrate inhibition. This apparent inconsistency for the mouse enzyme (i.e.
that when DGLA is PL-esterified it is the preferred substrate,
but when free it is a poor substrate compared with AA) can be
understood in terms of the steric constraints a PL-esterified
substrate might impose on whether or how the LOX can align
the substrate pentadiene for attack. The same constraints that
force the bulky phospholipid head group to be on the surface of
the enzyme and set the direction of entry of the fatty acid tail
first into the active site may also mitigate substrate inhibition.
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Substrate inhibition by the free PUFA suggests it can bind in the
active site in non-productive modes. The presence of the PL
head group might preclude non-productive substrate-enzyme
interactions and obviate substrate inhibition by simply restricting its modes of binding.
Product Specificity Is Context-dependent—One must also
consider the effect of experimental context on product specificity. Although overexpression of 15-LOX-2 in HEK cells leads
to an increase in only 15-HETE and 15-HETrE products in cell
extracts, the cell extracts from HEK cells expressing m8S-LOX
contain isomers not observed in the nanodisc assays (or with
free AA). The explanation for this apparent discrepancy could
be simply that the nanodisc assays do not incorporate the variety of PL-esterified AA the enzyme can encounter in HEK cells.
However, there is precedent for compromised product specificity in conditions in which the enzymatic reaction is slowed, as
it is for m8S-LOX at the bilayer. It has been reported that soybean LOX generates a unique regio- and stereospecific product
from cholate-solubilized PL substrate (38). However, when the
same substrate was incorporated into liposomes, a random
product mixture was observed. A random product mixture is
not observed when a free fatty acid substrate is presented in
liposomes (14). This loss of specificity can be understood in
terms of the LOX enzymatic mechanism. The reaction is initiated by hydrogen abstraction from the central carbon of the
pentadiene (Fig. 8). An O2 pocket positions molecular oxygen
for attack on the incipient radical. The membrane-embedded
substrate is constrained and cannot assume optimal alignment
in the enzyme active site; this distortion leads to a significantly
slowed reaction and allows exposure of the free radical intermediate to O2 in an alternate conformation. A similarly compromised specificity was observed at low O2 concentrations for
rabbit 15-LOX-1 (15). The overall interpretation is that if the
lifetime of the free radical intermediate is prolonged, alternative positioning in, or even escape from, the active site can lead
to a less specific pattern of oxygenation.
Our in vitro observations with the m8S-LOX can be understood in this context. The enzymatic reaction is significantly
slowed when the enzyme works at the bilayer. This slowed
enzymatic rate may be the source of the additional HETEs
detected. However, despite this slower reaction rate, one can
see from Fig. 6B that the total amount of HETEs produced by
m8S-LOX in HEK cells may even be greater than that produced
by 15-LOX-2 under equivalent conditions. Yet this result too is
consistent with the in vitro experiments. Recall that m8S-LOX
is not readily released from the nanodisc: although 15-LOX-2
effectively hops among nanodiscs, m8S-LOX remains stuck
and cannot access all available substrate. This same property—
that m8S-LOX scoots rather than hops—may allow m8S-LOX
to process more substrate than 15-LOX-2 in a cellular context,
even though it means less substrate with the limited small size
of a nanodisc.
The combined results led us to ask which experimental system, nanodiscs or HEK cell expression, accurately emulates the
m8S-LOX in vivo activity? Both have their shortcomings. As
mentioned above, the PL composition of the ND is not as
diverse as that in HEK cells, and all possible substrates are not
evaluated. On the other hand, constitutive overexpression of
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the enzyme in HEK cells cannot incorporate any regulatory
events that may occur in a biological context. However, what we
can clearly conclude is that m8S-LOX is active at the bilayer,
because in both nanodiscs and HEK cells, it generates products
that are not seen when the substrate is free AA and that are
consistent with tail end entry. The data indicate that that m8SLOX can produce other HETE isomers in addition to 8-HETE
and should not be ignored as a possible source of 15-HETE in
mouse models of atherosclerosis. When mouse models are
used, it should be considered that the potentially disease causing enzyme differs in significant aspects from the human homologue, and small molecule inhibitors used to target membrane activity of the mouse enzyme may not be effective against
the human enzyme.
Concluding Remarks—Both 15-LOX-2 and its murine counterpart (78% sequence identity), which generates 8-HpETE
from free AA, produce a PL-esterified 15-HpETE when the substrate is incorporated in a bilayer. Experiments with stably
transfected HEK cells suggest that these activities can contribute to cellular pools of free 15-HpETE/15-HETE. Despite the
fact that the homologous enzymes generate the same product
when they function at the bilayer, they differ significantly in
their interactions with the membrane. The interaction of
15-LOX-2 with the bilayer is reversible despite the presence of
Ca2⫹, whereas that for m8S-LOX is not.

Materials and Methods
LOX Cloning, Overexpression, and Purification—15-LOX-2,
m8S-LOX, and their loop mutants were overexpressed and
purified essentially as previously described for 15-LOX-2 (10).
For all Escherichia coli overexpression, the pET Duet-1 vector
with the E. coli yjgD gene after promoter 2 was used. Wild-type
and mutant 15-LOX-2 plasmids were previously generated
(10); the m8S-LOX plasmid was created as follows from a pet3C
plasmid obtained as a gift from the laboratory of Alan Brash.
The m8S-LOX gene was first cloned from pET3C to pET28a
using the restriction sites NdeI and HindIII. The m8S gene was
amplified from pET28a using primers with BspHI and HindIII
restriction sites, and the PCR product was cut with BspHI and
HindIII and inserted into the pET-Duet-1 vector cut with NcoI
and HindIII. BspHI and NcoI restriction sites have the same
sticky ends and can be annealed to each other. The BspHI site
was used at the 5⬘ end of the m8S gene instead of NcoI because
of the internal NcoI site in m8S. Cloning was confirmed by
sequencing the final pET-Duet-1 vector. The pET-Duet-1 vectors with desired genes were transformed into Rosetta 2 (DE3)
cells, and the overexpression was performed as described previously (10).
Enzymes were purified on a Talon Co2⫹ affinity column
using gravity flow and a step gradient. After protein binding, the
resin was washed with two column volumes of 20 mM Tris (pH
8.0), 500 mM NaCl, 20 mM imidazole. The enzymes were eluted
with 20 mM Tris (pH 8.0), 500 mM NaCl, 200 mM imidazole.
After the Talon affinity column the 15-LOX-2 samples were
highly purified. For m8S-LOX, 20% glycerol was added to the
purification and storage buffers as done by Kawajiri et al. (11);
otherwise protein activity was rapidly lost. The m8S-LOX was
further purified by size exclusion chromatography on a SuperSEPTEMBER 9, 2016 • VOLUME 291 • NUMBER 37

dex 200 column mounted on an AKTA FPLC (GE Healthcare)
and eluted with 20 mM Tris-HCl (pH 8.0), 250 mM NaCl.
Nanodisc Preparation—Nanodiscs were prepared according
to previously published protocols (10, 39). During the preparation of the phospholipid pellets, the desired ratios of the various
sn2 fatty acids and lipid head groups were adjusted. Nanodisc
concentration was calculated from the extinction coefficient of
the MSPE3D1 protein: 26,600 M⫺1 cm⫺1, taking into consideration the two proteins per nanodiscs.
Extraction for Mass Spectrometry of Nanodiscs—Phospholipids were extracted from the enzyme-nanodisc incubations
using the Bligh/Dyer method (40). To 100 l of reaction volume, 700 l of distilled water was added, after which 2 ml of
methanol and 1 ml of CHCl3 were added using Pasteur pipettes.
The mixture was vortexed and incubated on the nutator for 20
min at 22 °C. Subsequently, 1 ml of chloroform and 1.8 ml of
distilled water were added, and the mixture was incubated
again on the nutator for 20 min. The mixture was centrifuged at
room temperature at 4000 rpm for 2 min. The lower lipid-containing layer containing was removed with a Pasteur pipette,
transferred to a glass tube, dried under a stream of N2, and
resuspended in a solution of 2:1 CHCl3:methanol. Analysis by
mass spectrometry was performed in the positive ion mode for
phospholipids with choline head groups (e.g. SAPC).
Enzyme Assays with Nanodiscs—Assays were set up using 3
M enzyme (either 15-LOX-2 or m8S-LOX) and 15 M nanodiscs in 50 mM potassium phosphate buffer (pH 7.4), 100 mM
NaCl, 0.5 mM EDTA, and 2 mM CaCl2, at 37 °C. For m8S-LOX,
10% glycerol was added to the reaction buffer. For studying the
time course of product formation, 40-l aliquots were removed
and flash frozen in liquid N2. The aliquots were then incubated
at 85 °C for 50 min to inactivate the LOX, and 0.1 mg/ml final
concentration of phospholipase A2 (PLA2, bee venom; Sigma)
was added to cleave the fatty acids (at 37 °C, 2 h) for HPLC
analysis, after reduction to their corresponding HETEs with
triphenylphosphine (TPP). The reactions were stopped with
equal volumes of methanol and TPP (TPP, 25 mg/100 ml). Prior
to solid phase extraction with C18 cartridges (UCT CLEAN-UP
C18 CEC1811Z), 3 l of 1 M HCl, 5 l of 50 ng/l prostaglandin
B1 (Cayman) standard, and 100 l of PBS were added to a
100-l stopped reaction mixture. The 100% methanol elutions
from the C18 cartridges were dried under a N2 stream and then
resuspended in the mobile phase (60% acetonitrile, 0.1% formic
acid) for isocratic reverse phase HPLC with a Supelco Discovery
HSC18 column monitored at 235 nm. The extinction coefficients used for the products 15-HETE and 15-hydroxy-eicosatrienoic acid (15-HETrE) were 27,000 and 23,000 M⫺1 cm⫺1,
respectively (41– 44). The amount of product was calculated
from comparing HPLC peak areas to the peak area of prostaglandin B1 standard of known concentration, correcting for the
difference in extinction coefficients.
Enzyme Kinetics with Free Substrates—The assays of
15-LOX-2 and m8S-LOX with the free substrates were performed in 50 mM Tris (pH 7.5), 150 mM NaCl, 0.5 mM EDTA,
with the addition of 5% glycerol to m8S-LOX buffers. The
enzyme concentration was 200 nM, and the substrate concentrations varied between 1 M and 40 M. When ethyl ester
derivatives of substrates were used, 20 mM cholic acid was
JOURNAL OF BIOLOGICAL CHEMISTRY
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included in reaction buffer. When there was no substrate inhibition, classical Michaelis-Menten equation was used to fit the
data. When there was substrate inhibition, the following equation was used in GraphPad Prism least square regression fitting
(45– 47) as shown in Equation 1.
V0 ⫽

V max
K M [S]n
1⫹ ⫹ n
关 S] Ki

(Eq. 1)

Kinetic Analysis of Reactions on Nanodiscs—The protocol for
analyzing kinetics of enzymes on lipid surfaces differs from
enzyme kinetics in solution (12, 48). Instead of analyzing the
data using the integrated Michaelis-Menten equation adapted
to interfacial reactions, which requires much higher precision
reaction progress curves, the curves created from the intensities of the product peaks from the HPLC assay were fit with the
one-phase association equation in GraphPad Prism software.
y ⫽ y 0 ⫹ 共 Plateau ⫺ y 0 兲 ⫻ 共 1 ⫺ e ⫺kx兲

(Eq. 2)

This equation describes a first order rise to a maximum for
product formation. The assumption is that it is a first order
reaction, where the rate is dependent only on the concentration
of one reactant, which is the phospholipid substrate concentration in the nanodisc. Rate constants observed with different
enzymes and PL substrates are compared under equivalent
conditions (e.g. same Ca2⫹ concentrations, buffers, and reaction conditions). In other reactions, the amounts of product
formed at a given time point were compared for different head
groups, different variants of the enzymes, and in different conditions, to assess the effects of these variables on the rate of
product formation.
Supplementation for PUFA Enrichment of HEK Cell
Membranes—The membranes of HEK293 cells are generally a
poor source of AA. The PUFA content of the cells was increased
by supplementation of the media with BSA, AA, and LA over
multiple growth cycles, as described below in the details of the
transfection procedure. To evaluate the effectiveness of the
supplementation, exogenous 15-LOX-2 and PLA2 were utilized
to detect the presence of 15-LOX-2 substrates in the membrane
fraction. To this end, HEK293 cells were resuspended in 20 ml
of lysis buffer (PBS, 1.5 mM CaCl2, 0.5 mM EDTA, protease
inhibitors, and sodium orthovanadate) to a final cell concentration of 2 million cells/ml. Lysates were passed through a
23-gauge needle 20 times to rupture cell membranes. Lysate
reaction volumes (10 ml) were maintained on ice. The
15-LOX-2 reactions were initiated at 37 °C by addition of
enzyme (final concentration, 0.8 M) to the lysate and incubated for 1 h at 37 °C. The reactions were either stopped with
methanol or processed further with PLA2 to release the fatty
acids in the PL sn2 position. Prior to the addition of PLA2 (450
l of 1 mg/ml, 2 h, 37 °C), 15-LOX-2 was heat-inactivated. The
lysates were processed for HPLC analysis as above, after clarification by centrifugation.
HEK293 Transfection and Mass Spectrometry Analysis of
Oxidized Fatty Acids—The 15-LOX-2 and m8S-LOX genes
were cloned into a pCDNA 3.1(⫹) vector using the NheI and
HindIII restriction sites. The constructs were transfected into
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HEK293 cells using Lipofectamine 3000 (Invitrogen) per manufacturer’s instructions. The cells that picked up the plasmid
were grown using G418 selection. The untransfected cells were
treated in parallel as negative control in experiments. The
unsaturated fatty acid content of HEK293 cells was boosted by
supplementing the growth medium (DMEM, 10% FBS (Atlanta
Biologicals), penicillin/streptomycin, and G418 (Sigma)) with
30 M (final concentration) AA, 30 M LA in solution with 15
M BSA (Sigma) for four cell passages (90% confluence to 40%
confluence every 3 days). The cells were harvested at 90% confluence with trypsin-EDTA and washed once with DMEM ⫹
BSA (2 mg/ml), once with PBS ⫹ BSA, and once with PBS ⫹
BSA ⫹ glucose (0.1%), and finally resuspended in PBS ⫹ glucose at ⬃0.5 million cells/ml. After additions of 0.5 mM CaCl2
and 5 M Ca ionophore A23187, the cells were incubated at
37 °C for 1 h and subsequently cooled on ice for 10 min. Pelleted
cells were processed for lipidomic analysis of oxidized fatty
acids (see below).
Oxidized Fatty Acid Analysis—Just before analysis, supernatants containing (50% methanol) from 3 ⫻ 106 cells were
diluted in water to a final methanol concentration of less than
15% and deuterated internal standards (see below for transitions) added. The methanolic solution was extracted using a
solid phase extraction cartridge (Strata Polymeric Reversed
Phase, 60 mg/ml; Phenomenex, Torrance, CA). The eluant (1
ml of methanol) was reconstituted in HPLC solvent A (8.3 mM
acetic acid, buffered to pH 5.7 with NH4OH). Solvent B was
acetonitrile/methanol (65/35, v/v). An aliquot of 20 l was
injected into an HPLC system, and separation of the different
metabolites was conducted using a C18 column (Kinetex 5 m
EVO C18 100A; Phenomenex) eluted at a flow rate of 300
l/min with the initial conditions, 35% B, held for 1 min. The
gradient was then increased from 35% to 75% solvent B in 8 min;
subsequently B was increased to 98% in 1 min and held for 5
min. The HPLC system was directly interfaced into the electrospray source of a triple quadrupole mass spectrometer (AB
SCIEX Q-Trap 5500; PE-Sciex, Thornhill, Canada) where mass
spectrometric analyses were performed in the negative ion
mode using multiple reaction monitoring of the specific transitions: d4 9-HODE m/z 299 3 172, d4 13-HODE m/z 299 3 198,
d8 5(S)-HETE m/z 327 3 116, 9-HETE m/z 319 3 123, 8-HETE
m/z 319 3 163, 11-HETE m/z 319 3 167, 8-HETrE m/z 321 3
157, 5-HETrE m/z 321 3 205, 15-HETrE m/z 321 3 221,
9-HODE m/z 2953171, 13-HODE m/z 295 3 195, 5-HETE
m/z 319 3 115, 15-HETE m/z 319 3 219, and 12-HETE m/z
319 3 179. Quantitation was performed using a standard isotope dilution curve for each of the lipid targets for which a
stable isotope standard was added (13-HODE, 9-HODE, and
5-HETE) and reference standard curves determined for each of
the other oxidized polyunsaturated fatty acids (unlabeled analytes obtained from Cayman Chemical, Ann Arbor, MI), using
d8 5(S)-HETE as the internal standard. Representative MS data
are presented in supplementary Figs. S1 and S2.
Immunofluorescence Labeling of 15-LOX-2 in Transfected
HEK293 Cells—Transfected HEK293 cells expressing 15-LOX-2,
wild-type and variants, were seeded out at 200 cells/ml in each well
of an Ibdi 12-well slide treated with 0.01% poly-L-lysine. After
24 –48 h at 37 °C and 5.0% CO2, 2.5 M A23187 Ca2⫹ ionophore
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was added to stimulate cells, which were then incubated for 5 min
at 37 °C, 5.0% CO2. The cells were fixed with 4% paraformaldye
and then washed three times with PBS. The samples were then
incubated with a 50 mM NH4Cl solution, followed by a wash cycle.
The cells were permeabilized with ice-cold acetone followed by an
additional wash cycle, blocked for 1 h with 10% donkey serum,
0.1% Tween 20 in PBS, and subsequently incubated overnight at
4 °C with a primary antibody solution consisting of a 1:1000 dilution of rabbit anti-15-LOX-2 and mouse anti-pan-cadherin (both
AbCam) antibodies in 0.1% Tween 20 PBS. After a wash cycle with
0.1% Tween 20 PBS, the cells were incubated with a secondary
antibody solution consisting a 1:10000 dilution of goat anti-rabbit
antibody Alexa Fluor 647 and donkey anti-mouse Alexa Flour 488
(both Invitrogen) in a 0.1% Tween 20 PBS solution. After another
wash cycle, the cells were incubated with 2 g/l DAPI solution
for 3 min followed by another wash cycle. Prolong Gold antifade
reagent and a coverslip were then added to the slide. The slide was
imaged with a Leica DM RXA2 upright microscope with a SensiCam QE 12-bit CCD camera using DAPI, FITC (pan-cadherin)
and Cy5 (15-LOX-2) filter channels followed by no neighbors
deconvolution image analysis.
Author Contributions—G. B. designed, performed, and interpreted
the experiments and wrote the paper. E. E. S. performed the immunofluorescence studies. C. U. performed the oxidized fatty acid mass
spectrometry. R. C. M. and M. E. N. conceived the studies and contributed to data interpretation and manuscript preparation.
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